Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Chandan K Sen, The Ohio State University
ClinicalTrials.gov Identifier:
NCT01573390
First received: April 5, 2012
Last updated: August 21, 2014
Last verified: August 2014
  Purpose
  1. Quantitative validation of non-contact oxygenation imaging by the CWC imaging system
  2. Quantitative validation of non-contact vascular function imaging by the CWC imaging system
  3. Evaluation of the clinical usability of the CWC imaging system for further technology development and engineering improvement

Condition
Quantitative Validation of Imaging System

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.

Further study details as provided by Ohio State University:

Biospecimen Retention:   None Retained

there is no biospecimen collection require in this protocol.


Estimated Enrollment: 50
Study Start Date: August 2011
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Healthy participants.

Detailed Description:

The hyperspectral imaging technique estimates cutaneous tissue oxygenation by illuminating tissue and detecting tissue reflectance at different wavelengths. One major advantage of hyperspectral imaging is non-invasive and non-contact detection of tissue functional properties. The dual-mode imaging system integrates hyperspectral and thermal imaging modalities for simultaneous assessment of cutaneous tissue oxygenation and vascular function. This clinical protocol is defined to validate the CWC system on healthy human subjects

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Interested healthy volunteers

Criteria

Inclusion Criteria:

  • Adult 18 years and older
  • No history of diabetes.
  • No history of vascular disease

Exclusion Criteria:

  • Under 18 years of age
  • Unable to provide informed consent
  • Prisoners
  • Current smoker
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01573390

Locations
United States, Ohio
The Ohio State University.
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Chandan K Sen
Investigators
Principal Investigator: Chandan K Sen, Ph.D. Ohio State University
  More Information

Publications:

Responsible Party: Chandan K Sen, Professor, The Ohio State University
ClinicalTrials.gov Identifier: NCT01573390     History of Changes
Other Study ID Numbers: 2010H0017
Study First Received: April 5, 2012
Last Updated: August 21, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Ohio State University:
Non-invasive
tissue-oxygenation
hyperspectral
CWC imaging system

ClinicalTrials.gov processed this record on October 23, 2014